Skip to main content
HR 6834 117th Congress House

Recall Unsafe Drugs Act of 2022

Official title: To provide for the mandatory recall of drugs regulated by the Food and Drug Administration.

Introduced: February 25, 2022 Introduced by: DeLauro, Rosa L. Democratic · Connecticut See on congress.gov
Health Administrative remediesConsumer affairsDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationGovernment information and archives
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 28, 2022
Referred to the Subcommittee on Health.
Feb 25, 2022
Referred to the House Committee on Energy and Commerce.
Feb 25, 2022
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action February 28, 2022

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Recall Unsafe Drugs Act of 2022

This bill authorizes the Food and Drug Administration (FDA) to order the recall of certain adulterated or misbranded drugs and contains other related provisions.

A producer of a medication must notify the FDA of the identity and location of a drug if the producer has reason to believe that (1) the drug is adulterated or misbranded, and (2) there is a reasonable probability that the drug will cause a threat of serious adverse health consequences or death to humans or animals.

If use of a drug may cause serious adverse health consequences or death, the FDA may order the producer to immediately cease distribution and notify affected individuals. After issuing such an order, the FDA may also order a recall after affording the producer an opportunity for an informal hearing.

If a drug presents an imminent threat of serious adverse health consequences or death, the FDA may order the producer to immediately recall the drug and notify affected individuals. The distributor may appeal such an order.

An individual or entity required to register as a producer of drugs or medical devices must have a recall plan in effect.

 Related & companion bills 2
  • HR 5578 Reintroduction of Recall Unsafe Drugs Act of 2020
  • HR 3688 Reintroduced Bill Recall Unsafe Drugs Act of 2023
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 6834: Recall Unsafe Drugs Act of 2022. 117th Congress. Open America. https://openamerica.io/bill/117-HR-6834/
MLA
"H.R. 6834: Recall Unsafe Drugs Act of 2022." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-6834/.
Bluebook (legal)
H.R. 6834, 117th Cong. (2026), https://openamerica.io/bill/117-HR-6834/.
Markdown link
[H.R. 6834: Recall Unsafe Drugs Act of 2022](https://openamerica.io/bill/117-HR-6834/)
Report a problem